Vaccines
News
Moderna warns of material drop in vaccine efficacy against Omicron
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
News
Pfizer COVID vaccine is 100% effective in adolescents: Study
The clinical trial researchers found no serious safety concerns while following patients for 6 months.
News from the FDA/CDC
CDC: All adults should be eligible for Pfizer, Moderna boosters
More than 70 million adults are now eligible for booster shots in the United States, but only about 31 million people have received one.
Conference Coverage
mRNA COVID vaccine response found mostly robust in RA, SLE patients
A trial found that immunosuppressed adults with autoimmune disease had a robust antibody response to the mRNA vaccine with no excess adverse...
News
Pfizer seeks EUA expansion for COVID-19 booster
Pfizer is submitting a study of booster effects on 10,000 people to make its case.
News
COVID vaccines’ protection dropped sharply over 6 months: Study
“Although vaccination remains protective against SARS-CoV-2 infection, protection waned as the Delta variant emerged in the U.S.”
News
ACIP recommends HBV vaccination for all adults under 60
“The past decade has illustrated that risk-based screening has got us as far as it can take us.”
News
Success of HPV vaccination: ‘Dramatic’ reduction in cervical cancer
Among young women who received the HPV vaccine when they were 12-13 years old, cervical cancer rates are 87% lower than among previous...
Commentary
Q&A: Meeting the challenge of giving COVID vaccines to younger kids
Pediatric experts share best practices for meeting the challenges of immunizing children aged 5-11 years.
News
FDA authorizes Pfizer’s COVID-19 vaccine for kids
As soon as the CDC’s director signs off on those recommendations, children can get the shots, perhaps as early as Nov. 3.